Pacific Biosciences of California, Inc.
PACB
$1.32
$0.043.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -24.74% | -19.57% | -28.32% | -36.61% | -38.26% |
| Total Receivables | -3.57% | -7.25% | 28.79% | 4.20% | -0.54% |
| Inventory | 13.46% | -5.53% | -16.12% | -19.14% | -21.51% |
| Prepaid Expenses | -22.18% | -14.91% | -42.53% | -33.36% | -27.71% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -89.00% | -97.25% | -97.10% | -56.52% | -12.28% |
| Total Current Assets | -18.08% | -16.95% | -24.34% | -32.52% | -34.19% |
|
|
|||||
| Total Current Assets | -18.08% | -16.95% | -24.34% | -32.52% | -34.19% |
| Net Property, Plant & Equipment | 1.05% | -5.75% | 41.30% | 31.27% | 16.24% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | -13.90% | -13.90% |
| Goodwill | 0.00% | 0.00% | 0.00% | -13.90% | -13.90% |
| Total Other Intangibles | -23.77% | -22.43% | -96.12% | -96.30% | -96.13% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 42.87% | 47.01% | -4.91% | -6.59% | -9.98% |
| Total Assets | -8.92% | -9.11% | -37.79% | -44.61% | -45.31% |
|
|
|||||
| Total Accounts Payable | 27.69% | -3.05% | 25.20% | 35.63% | -13.91% |
| Total Accrued Expenses | -9.31% | 19.61% | 25.42% | 23.11% | -7.14% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 18.04% | -39.51% | -95.53% | -66.08% | -70.35% |
| Total Finance Division Other Current Liabilities | 30.56% | -13.87% | 35.56% | 8.49% | -22.40% |
| Total Other Current Liabilities | 30.56% | -13.87% | 35.56% | 8.49% | -22.40% |
| Total Current Liabilities | 15.15% | -1.87% | 9.85% | 5.35% | -23.77% |
|
|
|||||
| Total Current Liabilities | 15.15% | -1.87% | 9.85% | 5.35% | -23.77% |
| Long-Term Debt | -0.33% | -0.33% | -0.33% | -27.77% | -27.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.02% | 16.89% | 279.46% | 220.68% | 165.45% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 101.45% | 96.98% | -84.38% | -83.62% | -77.99% |
| Total Liabilities | 2.76% | 1.41% | 3.30% | -23.06% | -24.86% |
|
|
|||||
| Common Stock & APIC | 1.40% | 1.49% | 1.70% | 3.37% | 3.65% |
| Retained Earnings | -5.02% | -4.99% | -25.43% | -23.41% | -25.18% |
| Treasury Stock & Other | -288.39% | -138.58% | 8.29% | -73.28% | 151.05% |
| Total Common Equity | -154.01% | -97.42% | -98.94% | -92.04% | -87.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -154.01% | -97.42% | -98.94% | -92.04% | -87.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -154.01% | -97.42% | -98.94% | -92.04% | -87.52% |
|
|
|||||